The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats

Naoki Hasegawa, Thomas G. Kandra, Ahmad W. Husari, Steve Veiss, William T. Hart, Joe Hedgpeth, Robert Wydro, Thomas A. Raffin

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Activation of the coagulation system is postulated to play an important role in the pathogenesis of endotoxin-induced tissue injury. Thrombomodulin (TM) is an endothelial cell membrane glycoprotein receptor for thrombin. Once bound to TM, thrombin loses its procoagulant activity, which results in decreased clotting. In addition, the binding of thrombin to TM activates the endogenous anticoagulant pathway through protein C. We studied the effect of recombinant human TM (rh-TM) on endotoxin-induced multiple-system organ failure (MSOF) in Sprague-Dawley rats weighing 400 to 450 g: 2 mg/kg of rh- TM was injected (T1/2 = 4.5 h) 30 min prior to intravenous injection of 20 mg/kg of Escherichia coli endotoxin. The study presented here consisted of three separate experiments. Experiment 1: 24-h survival study. Experiment 2: multiple-system organ microthrombi study in which 125I-human fibrinogen was injected 30 min prior to an endotoxin or saline injection and tissue microthrombi formation was assessed by measuring the percentage of organ radioactivity (lung, heart, liver, and kidney) against total injected radioactivity (microthrombi index; MI) 2.25 h after an endotoxin or saline injection. Experiment 3: endotoxin-induced MSOF study in which 125I-rat albumin was injected 5 h after an endotoxin or saline injection, and endotoxin-induced organ injury was evaluated by measuring tissue wet-to-dry ratios (W/D) and tissue-to-plasma 125I-rat albumin concentration ratios (T/P) 8 h after the endotoxin or saline injection. Blood contamination in samples from Experiments 2 and 3 was corrected by using 131I-rat albumin measurements. Pretreatment with rh-TM improved the survival from 12 h through 23 h as compared with that of the endotoxin control group (p < 0.05). However, at 74 h, after essentially all injected rh-TM had been eliminated, there was no difference in survival. Significant reductions in MI, W/D, and T/P in the organs sampled were observed in the rh-TM pretreated groups (p < 0.05). In conclusion, rh-TM improved short-term but not overall survival and decreased MSOF in endotoxemic rats.

Original languageEnglish
Pages (from-to)1831-1837
Number of pages7
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume153
Issue number6 I
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Multiple Organ Failure
Endotoxins
Thrombomodulin
Albumins
Injections
Survival
Thrombin
Radioactivity
Thrombin Receptors
human THBD protein
Membrane Glycoproteins
Wounds and Injuries
Protein C
Intravenous Injections
Anticoagulants
Fibrinogen
Sprague Dawley Rats
Endothelial Cells
Cell Membrane
Kidney

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Hasegawa, N., Kandra, T. G., Husari, A. W., Veiss, S., Hart, W. T., Hedgpeth, J., ... Raffin, T. A. (1996). The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats. American Journal of Respiratory and Critical Care Medicine, 153(6 I), 1831-1837.

The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats. / Hasegawa, Naoki; Kandra, Thomas G.; Husari, Ahmad W.; Veiss, Steve; Hart, William T.; Hedgpeth, Joe; Wydro, Robert; Raffin, Thomas A.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 153, No. 6 I, 1996, p. 1831-1837.

Research output: Contribution to journalArticle

Hasegawa, N, Kandra, TG, Husari, AW, Veiss, S, Hart, WT, Hedgpeth, J, Wydro, R & Raffin, TA 1996, 'The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats', American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 6 I, pp. 1831-1837.
Hasegawa, Naoki ; Kandra, Thomas G. ; Husari, Ahmad W. ; Veiss, Steve ; Hart, William T. ; Hedgpeth, Joe ; Wydro, Robert ; Raffin, Thomas A. / The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats. In: American Journal of Respiratory and Critical Care Medicine. 1996 ; Vol. 153, No. 6 I. pp. 1831-1837.
@article{37e283be2d78493ba06586c56e3cf96e,
title = "The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats",
abstract = "Activation of the coagulation system is postulated to play an important role in the pathogenesis of endotoxin-induced tissue injury. Thrombomodulin (TM) is an endothelial cell membrane glycoprotein receptor for thrombin. Once bound to TM, thrombin loses its procoagulant activity, which results in decreased clotting. In addition, the binding of thrombin to TM activates the endogenous anticoagulant pathway through protein C. We studied the effect of recombinant human TM (rh-TM) on endotoxin-induced multiple-system organ failure (MSOF) in Sprague-Dawley rats weighing 400 to 450 g: 2 mg/kg of rh- TM was injected (T1/2 = 4.5 h) 30 min prior to intravenous injection of 20 mg/kg of Escherichia coli endotoxin. The study presented here consisted of three separate experiments. Experiment 1: 24-h survival study. Experiment 2: multiple-system organ microthrombi study in which 125I-human fibrinogen was injected 30 min prior to an endotoxin or saline injection and tissue microthrombi formation was assessed by measuring the percentage of organ radioactivity (lung, heart, liver, and kidney) against total injected radioactivity (microthrombi index; MI) 2.25 h after an endotoxin or saline injection. Experiment 3: endotoxin-induced MSOF study in which 125I-rat albumin was injected 5 h after an endotoxin or saline injection, and endotoxin-induced organ injury was evaluated by measuring tissue wet-to-dry ratios (W/D) and tissue-to-plasma 125I-rat albumin concentration ratios (T/P) 8 h after the endotoxin or saline injection. Blood contamination in samples from Experiments 2 and 3 was corrected by using 131I-rat albumin measurements. Pretreatment with rh-TM improved the survival from 12 h through 23 h as compared with that of the endotoxin control group (p < 0.05). However, at 74 h, after essentially all injected rh-TM had been eliminated, there was no difference in survival. Significant reductions in MI, W/D, and T/P in the organs sampled were observed in the rh-TM pretreated groups (p < 0.05). In conclusion, rh-TM improved short-term but not overall survival and decreased MSOF in endotoxemic rats.",
author = "Naoki Hasegawa and Kandra, {Thomas G.} and Husari, {Ahmad W.} and Steve Veiss and Hart, {William T.} and Joe Hedgpeth and Robert Wydro and Raffin, {Thomas A.}",
year = "1996",
language = "English",
volume = "153",
pages = "1831--1837",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6 I",

}

TY - JOUR

T1 - The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats

AU - Hasegawa, Naoki

AU - Kandra, Thomas G.

AU - Husari, Ahmad W.

AU - Veiss, Steve

AU - Hart, William T.

AU - Hedgpeth, Joe

AU - Wydro, Robert

AU - Raffin, Thomas A.

PY - 1996

Y1 - 1996

N2 - Activation of the coagulation system is postulated to play an important role in the pathogenesis of endotoxin-induced tissue injury. Thrombomodulin (TM) is an endothelial cell membrane glycoprotein receptor for thrombin. Once bound to TM, thrombin loses its procoagulant activity, which results in decreased clotting. In addition, the binding of thrombin to TM activates the endogenous anticoagulant pathway through protein C. We studied the effect of recombinant human TM (rh-TM) on endotoxin-induced multiple-system organ failure (MSOF) in Sprague-Dawley rats weighing 400 to 450 g: 2 mg/kg of rh- TM was injected (T1/2 = 4.5 h) 30 min prior to intravenous injection of 20 mg/kg of Escherichia coli endotoxin. The study presented here consisted of three separate experiments. Experiment 1: 24-h survival study. Experiment 2: multiple-system organ microthrombi study in which 125I-human fibrinogen was injected 30 min prior to an endotoxin or saline injection and tissue microthrombi formation was assessed by measuring the percentage of organ radioactivity (lung, heart, liver, and kidney) against total injected radioactivity (microthrombi index; MI) 2.25 h after an endotoxin or saline injection. Experiment 3: endotoxin-induced MSOF study in which 125I-rat albumin was injected 5 h after an endotoxin or saline injection, and endotoxin-induced organ injury was evaluated by measuring tissue wet-to-dry ratios (W/D) and tissue-to-plasma 125I-rat albumin concentration ratios (T/P) 8 h after the endotoxin or saline injection. Blood contamination in samples from Experiments 2 and 3 was corrected by using 131I-rat albumin measurements. Pretreatment with rh-TM improved the survival from 12 h through 23 h as compared with that of the endotoxin control group (p < 0.05). However, at 74 h, after essentially all injected rh-TM had been eliminated, there was no difference in survival. Significant reductions in MI, W/D, and T/P in the organs sampled were observed in the rh-TM pretreated groups (p < 0.05). In conclusion, rh-TM improved short-term but not overall survival and decreased MSOF in endotoxemic rats.

AB - Activation of the coagulation system is postulated to play an important role in the pathogenesis of endotoxin-induced tissue injury. Thrombomodulin (TM) is an endothelial cell membrane glycoprotein receptor for thrombin. Once bound to TM, thrombin loses its procoagulant activity, which results in decreased clotting. In addition, the binding of thrombin to TM activates the endogenous anticoagulant pathway through protein C. We studied the effect of recombinant human TM (rh-TM) on endotoxin-induced multiple-system organ failure (MSOF) in Sprague-Dawley rats weighing 400 to 450 g: 2 mg/kg of rh- TM was injected (T1/2 = 4.5 h) 30 min prior to intravenous injection of 20 mg/kg of Escherichia coli endotoxin. The study presented here consisted of three separate experiments. Experiment 1: 24-h survival study. Experiment 2: multiple-system organ microthrombi study in which 125I-human fibrinogen was injected 30 min prior to an endotoxin or saline injection and tissue microthrombi formation was assessed by measuring the percentage of organ radioactivity (lung, heart, liver, and kidney) against total injected radioactivity (microthrombi index; MI) 2.25 h after an endotoxin or saline injection. Experiment 3: endotoxin-induced MSOF study in which 125I-rat albumin was injected 5 h after an endotoxin or saline injection, and endotoxin-induced organ injury was evaluated by measuring tissue wet-to-dry ratios (W/D) and tissue-to-plasma 125I-rat albumin concentration ratios (T/P) 8 h after the endotoxin or saline injection. Blood contamination in samples from Experiments 2 and 3 was corrected by using 131I-rat albumin measurements. Pretreatment with rh-TM improved the survival from 12 h through 23 h as compared with that of the endotoxin control group (p < 0.05). However, at 74 h, after essentially all injected rh-TM had been eliminated, there was no difference in survival. Significant reductions in MI, W/D, and T/P in the organs sampled were observed in the rh-TM pretreated groups (p < 0.05). In conclusion, rh-TM improved short-term but not overall survival and decreased MSOF in endotoxemic rats.

UR - http://www.scopus.com/inward/record.url?scp=0030014232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030014232&partnerID=8YFLogxK

M3 - Article

C2 - 8665042

AN - SCOPUS:0030014232

VL - 153

SP - 1831

EP - 1837

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6 I

ER -